ReCode Therapeutics

Back to Search

ReCode Therapeutics

Categories

Core Members

Core Membership

About

ReCode Therapeutics is a clinical-stage genetic medicines company using superior delivery to power the next wave of mRNA and gene correction therapeutics. ReCode’s selective organ targeting (SORT) lipid nanoparticle (LNP) platform is a next-generation, genetic medicines technology that enables precise delivery to target organs and cells beyond the liver.

Membership Type

Core Membership

Powered By GrowthZone